JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB243229

Anti-BST2/Tetherin antibody [EPR20202-169]

Be the first to review this product! Submit a review

|

(4 Publications)

Rabbit Recombinant Monoclonal BST2/Tetherin antibody. Suitable for IP, Flow Cyt, WB, ICC/IF and reacts with Human samples. Cited in 4 publications.

View Alternative Names

CD317, Bone marrow stromal antigen 2, BST-2, HM1.24 antigen, Tetherin, BST2

7 Images
Immunocytochemistry/ Immunofluorescence - Anti-BST2/Tetherin antibody [EPR20202-169] (AB243229)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-BST2/Tetherin antibody [EPR20202-169] (AB243229)

Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized U-937 (human histiocytic lymphoma cell line) cells labeling BST2/Tetherin with ab243229 at 1/100 dilution, followed by Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (Green). Confocal image showing cytoplasmic staining in U-937 cells (PMID : 20529266).

The nuclear counter stain is DAPI (blue). Tubulin is detected with Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) (ab195889) (red) at 1/200 dilution.

Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution.

Flow Cytometry - Anti-BST2/Tetherin antibody [EPR20202-169] (AB243229)
  • Flow Cyt

Unknown

Flow Cytometry - Anti-BST2/Tetherin antibody [EPR20202-169] (AB243229)

Flow cytometric analysis of HeLa (Human epithelial cell line from cervix adenocarcinoma) cell line labeling BST2/Tetherin with ab243229 at 1/500 dilution (Red) compared with a Rabbit IgG, monoclonal [EPR25A] - Isotype Control (ab172730) (black) and an unlabeled control (cells without incubation with primary antibody and secondary antibody) (blue). Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) at 1/2000 dilution was used as the secondary antibody. Gated on viable cells.

Flow Cytometry - Anti-BST2/Tetherin antibody [EPR20202-169] (AB243229)
  • Flow Cyt

Unknown

Flow Cytometry - Anti-BST2/Tetherin antibody [EPR20202-169] (AB243229)

Flow cytometric analysis of U-937 (human histiocytic lymphoma cell line) cell line labeling BST2/Tetherin with ab243229 at 1/500 dilution (red) compared with a Rabbit IgG, monoclonal [EPR25A] - Isotype Control (ab172730) (black) and an unlabeled control (cells without incubation with primary antibody and secondary antibody) (blue). Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) at 1/2000 dilution was used as the secondary antibody. Gated on viable cells.

Immunocytochemistry/ Immunofluorescence - Anti-BST2/Tetherin antibody [EPR20202-169] (AB243229)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-BST2/Tetherin antibody [EPR20202-169] (AB243229)

Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized HeLa (human epithelial cell line from cervix adenocarcinoma) cells labeling BST2/Tetherin with ab243229 at 1/100 dilution, followed by Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (Green). Confocal image showing cytoplasmic staining in HeLa cells (PMID : 20529266).

The nuclear counter stain is DAPI (blue). Tubulin is detected with Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) (ab195889) (red) at 1/200 dilution.

Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution.

Immunoprecipitation - Anti-BST2/Tetherin antibody [EPR20202-169] (AB243229)
  • IP

Unknown

Immunoprecipitation - Anti-BST2/Tetherin antibody [EPR20202-169] (AB243229)

BST2/Tetherin was immunoprecipitated from 0.35 mg HeLa (human epithelial cell line from cervix adenocarcinoma) whole cell lysate with ab243229 at 1/30 dilution. Western blot was performed on the immunoprecipitate using ab243229 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366) was used for detection at 1/5000 dilution.

Lane 1 : HeLa whole cell lysate 10 μg (input).
Lane 2 : ab243229 IP in HeLa whole cell lysate.
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab243229 in HeLa whole cell lysate.

Blocking/Diluting buffer and concentration : 5% NFDM/TBST
Exposure time : 3 seconds.

All lanes:

Immunoprecipitation - Anti-BST2/Tetherin antibody [EPR20202-169] (ab243229)

Predicted band size: 20 kDa

false

Western blot - Anti-BST2/Tetherin antibody [EPR20202-169] (AB243229)
  • WB

Unknown

Western blot - Anti-BST2/Tetherin antibody [EPR20202-169] (AB243229)

Blocking/Diluting buffer and concentration : 5% NFDM/TBST

The expression profile/ molecular weight observed is consistent with what has been described in the literature (PMID : 19196977; PMID : 19737401).

BST2/Tetherin is a glycosylated protein, its calculated MW is 20kDa, and the observed MW is 35 kDa, which is consistent to the literature.

Both 35 and 70-kDa bands were detected under the reducing condition, whereas under the non-reducing condition, only the 70-kDa band was detected.

All lanes:

Western blot - Anti-BST2/Tetherin antibody [EPR20202-169] (ab243229) at 1/1000 dilution

Lane 1:

HeLa (human epithelial cell line from cervix adenocarcinom), whole cell lysate, in the loading buffer containing DTT at 20 µg

Lane 2:

HeLa whole cell lysate in the loading buffer without DTT at 20 µg

Lane 3:

K562 (human chronic myelogenous leukemia lymphoblast), whole cell lysate, in the loading buffer containing DTT at 20 µg

Lane 4:

K562 whole cell lysate in the loading buffer without DTT at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution

Predicted band size: 20 kDa

Observed band size: 35 kDa,70 kDa

false

Exposure time: 48s

Western blot - Anti-BST2/Tetherin antibody [EPR20202-169] (AB243229)
  • WB

Unknown

Western blot - Anti-BST2/Tetherin antibody [EPR20202-169] (AB243229)

Blocking/Diluting buffer and concentration : 5% NFDM/TBST.

The expression profile/ molecular weight observed is consistent with what has been described in the literature (PMID : 19737401)

All lanes:

Western blot - Anti-BST2/Tetherin antibody [EPR20202-169] (ab243229) at 1/1000 dilution

All lanes:

U937 (human histiocytic lymphoma cell line) whole cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution

Predicted band size: 20 kDa

Observed band size: 35 kDa,70 kDa

false

  • Carrier free

    Anti-BST2/Tetherin antibody [EPR20202-169] - BSA and Azide free

  • Carrier free

    Anti-BST2/Tetherin antibody [EPR20202-169] - BSA and Azide free (Detector)

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR20202-169

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

WB, ICC/IF, IP, Flow Cyt

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/30", "IP-species-notes": "<p></p>", "FlowCyt-species-checked": "testedAndGuaranteed", "FlowCyt-species-dilution-info": "1/500", "FlowCyt-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/100", "ICCIF-species-notes": "<p></p>" } } }

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

IFN-induced antiviral host restriction factor which efficiently blocks the release of diverse mammalian enveloped viruses by directly tethering nascent virions to the membranes of infected cells. Acts as a direct physical tether, holding virions to the cell membrane and linking virions to each other. The tethered virions can be internalized by endocytosis and subsequently degraded or they can remain on the cell surface. In either case, their spread as cell-free virions is restricted (PubMed : 18200009, PubMed : 18342597, PubMed : 19036818, PubMed : 19879838, PubMed : 20019814, PubMed : 20399176, PubMed : 20419159, PubMed : 20940320, PubMed : 21529378, PubMed : 22520941). Its target viruses belong to diverse families, including retroviridae : human immunodeficiency virus type 1 (HIV-1), human immunodeficiency virus type 2 (HIV-2), simian immunodeficiency viruses (SIVs), equine infectious anemia virus (EIAV), feline immunodeficiency virus (FIV), prototype foamy virus (PFV), Mason-Pfizer monkey virus (MPMV), human T-cell leukemia virus type 1 (HTLV-1), Rous sarcoma virus (RSV) and murine leukemia virus (MLV), flavivirideae : hepatitis C virus (HCV), filoviridae : ebola virus (EBOV) and marburg virus (MARV), arenaviridae : lassa virus (LASV) and machupo virus (MACV), herpesviridae : kaposis sarcoma-associated herpesvirus (KSHV), rhabdoviridae : vesicular stomatitis virus (VSV), orthomyxoviridae : influenza A virus, paramyxoviridae : nipah virus, and coronaviridae : SARS-CoV (PubMed : 18200009, PubMed : 18342597, PubMed : 19179289, PubMed : 19879838, PubMed : 20399176, PubMed : 20419159, PubMed : 20686043, PubMed : 20943977, PubMed : 21529378, PubMed : 21621240, PubMed : 22520941, PubMed : 26378163, PubMed : 31199522). Can inhibit cell surface proteolytic activity of MMP14 causing decreased activation of MMP15 which results in inhibition of cell growth and migration (PubMed : 22065321). Can stimulate signaling by LILRA4/ILT7 and consequently provide negative feedback to the production of IFN by plasmacytoid dendritic cells in response to viral infection (PubMed : 19564354, PubMed : 26172439). Plays a role in the organization of the subapical actin cytoskeleton in polarized epithelial cells. Isoform 1 and isoform 2 are both effective viral restriction factors but have differing antiviral and signaling activities (PubMed : 23028328, PubMed : 26172439). Isoform 2 is resistant to HIV-1 Vpu-mediated degradation and restricts HIV-1 viral budding in the presence of Vpu (PubMed : 23028328, PubMed : 26172439). Isoform 1 acts as an activator of NF-kappa-B and this activity is inhibited by isoform 2 (PubMed : 23028328).
See full target information BST2

Publications (4)

Recent publications for all applications. Explore the full list and refine your search

JCO precision oncology 9:e2500404 PubMed40749151

2025

Mucin 16-Directed Therapy in Pediatric Sarcomas: Case Evidence of Ubamatamab Efficacy in Epithelioid Sarcoma and Its Implications for Other Sarcoma Subtypes.

Applications

Unspecified application

Species

Unspecified reactive species

Denise M Connolly,Gabriel Revon-Rivière,Rose Chami,Denise Mills,Ailish C Coblentz,Thomas S Uldrick,David A Knorr,Priscila Goncalves,Michael Dobosz,Sumreen Jalal,Sarah Cohen-Gogo,Daniel A Morgenstern

Genome medicine 16:148 PubMed39696540

2024

Spatial transcriptome profiling identifies DTX3L and BST2 as key biomarkers in esophageal squamous cell carcinoma tumorigenesis.

Applications

Unspecified application

Species

Unspecified reactive species

Rutao Li,Na Li,Qianqian Yang,Xing Tong,Wei Wang,Chang Li,Jun Zhao,Dong Jiang,Haitao Huang,Chen Fang,Kai Xie,Jiamin Yuan,Shaomu Chen,Guangbin Li,Haitao Luo,Zhibo Gao,Dongfang Wu,Xiaoli Cui,Wei Jiang,Lingchuan Guo,Haitao Ma,Yu Feng

Frontiers in immunology 12:669241 PubMed34025670

2021

Epigenetic Regulation of Expression Levels and the Effect on HIV-1 Pathogenesis.

Applications

Unspecified application

Species

Unspecified reactive species

Ravesh Singh,Veron Ramsuran,Vivek Naranbhai,Nonhlanhla Yende-Zuma,Nigel Garrett,Koleka Mlisana,Krista L Dong,Bruce D Walker,Salim S Abdool Karim,Mary Carrington,Thumbi Ndung'u

Cells 10: PubMed33800686

2021

Parkinson's Disease Causative Mutation in Vps35 Disturbs Tetherin Trafficking to Cell Surfaces and Facilitates Virus Spread.

Applications

Unspecified application

Species

Unspecified reactive species

Yingzhuo Ding,Yan Li,Gaurav Chhetri,Xiaoxin Peng,Jing Wu,Zejian Wang,Bo Zhao,Wenjuan Zhao,Xueyi Li
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com